Adverse events associated with hormonal contraception: Predisposing factors and prevention strategies
International Health Sciences Review · 23.04.2026 · 2 (2)
DOI: 10.70164/ihsr.v2i2.161 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Health Sciences Review, online erschienen am 23.04.2026. Verfasst von Jamile Zampieri Fernandes und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Patientensicherheit
Abstract (Originalsprache)
Hormonal contraception remains a cornerstone of reproductive health, but its safety profile requires careful clinical assessment because adverse events persist despite the transition from high-dose to lower-dose formulations. This review aimed to analyze the main adverse events associated with hormonal contraception, identify the principal predisposing factors, and discuss evidence-based prevention strategies applicable to clinical practice. A structured literature review was conducted using PubMed and Cochrane Library, prioritizing clinical guidelines, systematic reviews, meta-analyses, and major observational studies addressing hormonal contraceptives, thrombosis, cardiovascular risk, metabolic effects, and patient safety. The evidence indicates that the most severe adverse outcomes are primarily associated with estrogen-containing methods, especially combined hormonal contraceptives, with venous thromboembolism, ischemic stroke, myocardial infarction, and blood pressure elevation representing the main serious concerns. Risk is modified by patient-related factors such as obesity, smoking, age, hypertension, migraine with aura, inherited thrombophilia, and prior thrombotic disease. Minor adverse effects, including irregular bleeding, mood changes, and sexual complaints, are also clinically relevant because they often impair adherence and continuation. Most serious adverse events are potentially preventable through individualized risk stratification, de tailed anamnesis, blood pressure assessment, and appropriate application of medical eligibility criteria, with progestin-only and long-acting reversible methods often representing safer alternatives in higher-risk populations.
Zitieren
APA
Fernandes, J. Z., Lamb, M. J., Naves, J. V., & Costa, J. T. R. (2026). Adverse events associated with hormonal contraception: Predisposing factors and prevention strategies. International Health Sciences Review, 2(2). https://doi.org/10.70164/ihsr.v2i2.161
Vancouver
Fernandes JZ, Lamb MJ, Naves JV, Costa JTR. Adverse events associated with hormonal contraception: Predisposing factors and prevention strategies. International Health Sciences Review. 2026;2(2). doi:10.70164/ihsr.v2i2.161
BibTeX
@article{Fernandes2026,
author = {Fernandes, Jamile Zampieri and Lamb, Maria Júlia and Naves, Julia Vasconcelos and Costa, Júlia Torres Rodrigues},
title = {Adverse events associated with hormonal contraception: Predisposing factors and prevention strategies},
journal = {International Health Sciences Review},
year = {2026},
volume = {2},
number = {2},
doi = {10.70164/ihsr.v2i2.161}
}
EUVIMED